Which is better, satelizumab (Anshiping) or rituximab?

Satralizumab and Rituximab are two different antibody drugs used to treat different types of diseases. Satelizumab is used to treat idiopathic neuromyelitis optica (NMOSD), which primarily affects the central nervous system, including the spinal cord and optic nerves. Satrolizumab reduces the number of attacks in NMOSD patients by suppressing specific immune responses and can help control the progression of the disease. Rituximab is mainly used to treat some autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and non-Hodgkin lymphoma. To determine which drug is better, factors such as the specific disease type, the patient's individual characteristics, and the clinical condition need to be considered.